Clinical Trial Update: Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial update evaluating varlitinib in combination with mFOLFOX6 as first-line therapy for advanced or metastatic gastric cancer has completed recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Varlitinib (varlitinib)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: COMPLETED